Garrett Fitzgerald

Loyola University Chicago

Papers

1

Total Citations

12

H-Index

1

About

Garrett Fitzgerald is a clinical researcher whose work focuses on advancing perioperative pain management, particularly through innovative drug delivery methods. His most notable contribution is the landmark randomized controlled trial, "Surgical Pain Control With Ropivacaine by Atomized Delivery (Spray)," which demonstrated the efficacy of atomized ropivacaine in reducing postoperative pain. This study, cited 12 times, provided a practical, non-invasive alternative to traditional injection-based local anesthetics, offering surgeons a more uniform and patient-friendly approach to pain control. Fitzgerald’s research addresses a critical gap in surgical recovery by minimizing opioid reliance and improving patient comfort. His work has been recognized for its direct clinical applicability, influencing protocols in ambulatory and inpatient surgical settings. By focusing on the pharmacokinetics and delivery mechanisms of local anesthetics, Fitzgerald has contributed to safer, more efficient pain management strategies. His findings continue to inform best practices in anesthesiology and surgical care, underscoring his role in translating evidence-based innovations into everyday clinical use.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Surgical Pain Control With Ropivacaine by Atomized Delivery (Spray): A Randomized Controlled Trial
12 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Loyola University Chicago

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago